PREFER
Start date:Historic End date:
June 2014 Co-ordinated by:
Daiichi Sankyo Deutschland GmbH, Munich
Prefer in VTE Prevention of Thromboembolic Events – European Registry in Venous Thromboembolism
Aim
To assess the 12 month direct health care resource use and estimated costs following acute first-time (initial) or recurrent VTE
Trial Design
Multi –national, multi-centre, prospective observational disease registry
Chief Investigator
Dr Petra Laeis, Munich
Local PI
Dr. Matt Reed
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
More EMERGE Trials
BRAINED Study
Molecular and cellular analysis of intracranial tumours
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.
PRECISE-CTCA Trial
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.